News

November 3, 2021

Swiss Gondola Medical Technologies Announces Collaboration with New York’s Mount Sinai Health System to Study Innovative Treatment for Neurological Disorders Such as Parkinson’s Disease

Automated Peripheral Mechanical Stimulation improves patient mobility Non-invasive mechanical device stimulates nerves in patients’ feet Custom-fitted “boots” ensure contact points alignment Device is internationally patented […]

October 21, 2021

Exacis Biotherapeutics Announces Strategic Partnership with CCRM for Specialty Manufacturing Services and Investment

Exacis Biotherapeutics Exacis uses proprietary mRNA-based cell engineering to develop off-the-shelf immune cell therapies for cancer treatment from induced pluripotent stem cells (iPSCs) Exacis has […]

September 10, 2021

Exacis Biotherapeutics Announces Key Additions to Company’s Scientific Advisory Board

Exacis Biotherapeutics Pamela Munster, MD, to advise on aspects of solid tumor treatment Caron Jacobson, MD, MMSc, to advise on cell therapy development and clinical […]

August 5, 2021

Aardvark Therapeutics, Inc., Completes $29M Series B Funding Led by Sorrento Therapeutics and Including Existing Investors and The Foundation for Prader-Willi Research

Funds will support three Phase 2 clinical trials of Aardvark’s lead compound to be initiated this year and advance additional products in the pipeline San […]